Black Diamond Therapeutics, Inc. (BDTX)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 04
-0.06
-2.8571%
After Hours
$
+0.09 +4.4118% 2. 13
120.33M Market Cap
- P/E Ratio
- Div Yield
759,094 Volume
-1.71 Eps
$ 2.1
Previous Close 
Want to track BDTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Black Diamond Therapeutics, Inc. (BDTX) Statistics
Valuation metrics
Market Cap 120.33M
Enterprise value 125.56M
Trailing P/E (ttm) -3.01
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) -
Price/Book (mrq) 1.33
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.07
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 521.91K
Average volume (90 days) 1.55M
Price summary
52-Week low 1.6
52-Week high 4.94
Beta -
50-Day moving average 1.81
200-Day moving average 2.41
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.34%
Return on equity -0.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.74
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.93
Total debt (mrq) -
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 7.28%
Book value per share (mrq) 1.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
